There
are a large number of myths and fairy tales about what causes ASD, and many
parents of children with the condition have spent many thousands of dollars
doing needless and sometimes harmful procedures in the faint hope that the
procedures will cure their child. It is clear, though, that they cause of
developmental delay in children is due to two or more deficiencies of the
children, whilst in the womb of a deficient mother. Thus, all children have been
found to be deficient in vitamin B2,
vitamin B12,
iron and/or
vitamin D. Despite this, people
with children with a child with autism appear to be desperate enough to try
anything, that has a vague, but non-proven chance of success. This is a very,
very costly non-solution to a basic biochemical deficiency. The
major problem with this way of thinking is that it has lead to the major
Paradigm of Autism There is currently no
cure for autism. The corollary to the paradigm is that if there really is
cure for autism, then leading experts and governments are somehow unaware or it,
and hence if there is a major breakthrough in autism treatment it would be
International news and everyone would know of it. This can be exemplified by the
complete lack of Scientific effort currently underway by many large
organizations working in the field of Autism Research Viz: "XYZ does not focus
on curing autism, XYZ is more interested in research efforts that will support
people on the autism specturm and their families and carers to realize and reach
their goals and aspirations". Clearly there will have to be a massive paradigm
shift in organizations such as the aforementioned before, would possibly
countenance any new scientific research. Even then it is likely, that the
individuals involved within the hierarchy of such organizations will have to
maintain a status of "cognitive dissonance" in order to justify or validate
their previous paradigm. One of the major problems with the Paradigm is that it
becomes self-fullfilling in that no-one working on the cause of autism will get
public funding, which may explain why up until now significant advancements have
not been made in the field. This is despite literally $100 million being spent
on research see
Donate It is
the object of the current page to dispel some of the more common myths and
thereby help to "Save the children". The
Nemechek protocol, is a protocol that appears to be based on the concept that
ASD is caused by inflammation, which "can be seen" by the high levels of the
so-called inflammatory markers, KA/QA/HVA/VMA observed in autism. Hence the
protocol is based on treating putative bacterial inflammation in the gut, and
thereby reducing inflammation, which is postulated to also be occurring in the
brain and therefore hindering development. The protocol involves treating with
high dose fish oil, olive oil and inulin. The problem with the protocol is the
assumption that high levels of KA/QA/HVA/VMA are due to inflammation, however,
these are not inflammatory markers, they are markers of vitamin B12 deficiency
(see https://b12oils.com/b12.htm ).
There are claims that the protocol has some benefit in some children, however,
this could be explained by high levels of vitamin K in the olive oil, and also
the high levels of vitamin D in Cod-liver oil. The later could be of some
benefit as it is known that the majority of children with ASD are vitamin D
deficient see
https://b12oils.com/vitamind.htm .Normal fish oil does not contain
significant amounts of vitamin D. For
many years, there was a belief that conditions such as ASD and CFS were caused
by heavy metal contamination in the brain, and that people would not make
significant progress unless the metals were somehow removed from the brain. The
"offending" metal was postulated by Dr Cutler (a physicist who is now dead) to
be mercury. Hence the Cutler protocol was "invented". In the protocol, repeated
high doses of proposed chelating agents meso-demercaptosuccinic acid (DMSA),
dimercaptopropanesulfonic acid (DMPS) and ALA (alphalipoic acid, or thioctic
acid). Use of both DMSA and DMPS have been shown to be effective at chelation of
Arsenic and Lead following acute exposure, when the material is still
circulating in the blood, ie the first 24 hours, but after that it is
ineffective. Further, these two chelators are fairly non-specific and so whilst
they will chelate lead and arsenic, they also chelate and eliminate essential
metals such as chromium, cobalt copper and iron, which are used for physiologic
function. Further there is no known method of transport whereby DMSA and/or DMPS
can actively target out some yet to be proven or identified deposit of mercury,
strip it off any neighbouring protein, and then use some yet to be identified
cellular expulsion method to selectively remove only the toxic metals without
removing other metals such as zinc, magnesium, calcium, copper, iron, etc.
Further, it is known that reagents such as DMSA and DMPS do not enter the brain.
The use of ALA is also controversial, hence the sulphur atoms in the structure
are disulfide linked and so are not available for chelation, or metal reduction.
ALA, is though, an essential co-factor in pyruvate dehydrogenase and in alpha-ketoglutarate
dehydrogenase, however, nearly half of the bodies ALA comes from the consumption
of meat. HMTA of children with ASD does not indicate levels of mercury any
higher than the average population. There has been no substantive evidence of
efficacy for the Cutler protocol. HMTA has though revealed many metal
deficiencies in ASD, including Calcium, Magnesium, Sodium, Potassium, and
critically Iodine, Selenium and Molybdenum. Side effects of the treatment
include vomiting, diarrhea, rash, low blood neutrophils.
In a
similar fashion to the Cutler Chelation Therapy, there are those who believe
that heavy metals can be specifically removed by nanosized zeolite-like
molecules. In the Advanced Toxin Removal System (Advanced
TRS), clinoptilolite zeolite is nanosized and encased in water. The concept
being that somehow these tiny particles can travel where ever water can move and
magically source out some heavy metal toxin, and just as magically remove it
specifically from the body without removing any of the essential metals. This
approach is naive at best, and further, HMTA of children with autism does not
show any increased concentration of toxic metals over and above those in the
local atmosphere. Bentonite clay is also used orally, but as any person who
works with small molecules such as vitamins and minerals knows, this is totally
non-specific and will leave the recipient even more depleted in essential
vitamins and minerals.
There are a group of individuals "Anti-vaxxers" who believe that there is a
connection between vaccination and autism, and the concept has arisen that
children become vaccine injured, which then causes autism. One of the early
theories revolved around the use of thiomersal as a preservative in vaccines.
The use of thiomersal has now been discontinued, however the rate of autism
has risen from one in one thousand to now one in thirty-forty in the USA, over
the past 20 years, yet vaccination rates have remained the same. Potentially
vaccines, though, could, and should promote strong immune responses to the
vaccinating antigens. The generation of such immune responses is critically
dependent upon the activation of phagocytic cells, such as Macrophages. The
immune response would then consume large quantities of vitamin B2, iron, vitamin
B12 and vitamin D. Given that deficiencies in each of B2, B12, iron and vitamin
D have all been shown to be predisposing factors for the development of ASD, any
child who was "marginal" in these nutrients could have a negative response to
vaccine. For this reason, any person being vaccinated should ensure that they
receive adequate intake of vitamin B2 (plus Iodine, Selenium and Molybdenum),
vitamin B12, iron and vitamin D, at time of vaccination. This will ensure that
the child has a better immune response to the vaccination protocol, and has less
chance of being affected by vaccination. Many
of the children with ASD have been found to have elevated propionic acid, and
this has been postulated to cause the condition. Propionic acid
(CH3-CH2-COOH)(C3H6O2) is a normal metabolite of odd chain
fatty acids, and also can come from the deamination of Alanine
(CH3CH-NH2-COOH). In functional vitamin B2 deficiency, which every child with
ASD that we have
data for has, they cannot gain sufficient energy from fats or sugars and
so have to gain it from protein breakdown, and so metabolites of amino acids
start to appear in the urine, particularly if there are other deficiencies.
Normally, propionic acid is processed by the biotin-dependent enzyme
Propionyl-CoA carboxylase, but in biotin deficiency, which most of the kids
have, particularly if they have been put on a diet low in eggs, they can't do
this and so elevated levels of propionic acid can be found. Generally this is
accompanied by elevated levels of methylcitrate in the Orgnic Acids Test. Hence
biotin replete, neurotypic individuals have methyl citrate of 0.6471 +/- 0.38,
whilst in ASD this is increased to 1.37 +/- 0.7724. Many ASD individuals have
levels much higher than this with data in the 2.0 to 5.0 not being uncommon. The
elevated Methylcitrate and propionic acid resolve upon treatment with 150-300 ug/day
biotin. "Propionic
acidemia is due to deficient activity of the enzyme propionyl-CoA carboxylase.
Because propionyl-CoA requires biotin as a cofactor, disorders of biotin also
cause propionic acidemia."
The ability of a cell to trap and retain folate is dependent upon
the addition of a polyglutamate tail on folate. This tail is "added" once folate
enters the folate cycle by the enzyme folylpolyglutamate synthetase (FPGS). In
methyl B12 deficiency dietary folate - which is primarily 5MTHF is not processed
by methionine synthase and so is not converted to tetrahydrofolate, and so
cannot enter the folate cycle to be polyglutaminated. The result is that
intracellular folate levels are low, despite the observation that serum folate
levels may be high. This has lead to the concept of Cerebral Folate deficiency.
Yes, there is a deficiency of folate in most cells in the body, including the
brain, but this has arisen due the universal functional vitamin B12 deficiency,
observed in ASD. Worryingly, one of the
procedures used to establish Cerebral Folate deficiency is the totally
unnecessary lumbar puncture of the spine. This technique carries signficant
risks including: Damage to a
nerve root can cause severe pain, numbness, weakness, and increased sensitivity,
Cerebral herniation, in which the brain falls out of the skull and into the
spinal canal, Peripheral compartment syndrome, Post-lumbar puncture headache,
which occurs in up to 25% of people who have undergone a lumbar puncture due to
a leak of fluid into nearby tissues, Back discomfort or pain radiating down the
legs, Bleeding at the puncture site, Brainstem herniation. Given that even if
cerebral folate is determined, what would be the outcome. Functional vitamin B12
sufficiency would still need to be established. Little to no gain, for a lot of
pain and a high risk.
Production of GABA, an inhibitory neurotransmitter in the body requires the
conversion of Glutamate to GABA by the enzyme Glutamic Acid Decarboxylase (GAD).
This enzyme requires the active form of vitamin B6, pyridoxal-phosphate as a
co-factor. Production of PLP, however, requires one of the two active forms of
vitamin B2, FMN. In deficiency of Iodine and/or Selenium, levels of FMN are
reduced, resulting in elevated glutamate and reduced GABA, with an altered
glutamate/GABA ratio. Treatment should consist of fixing the functional B2
deficiency. Current "mistreatments" include restrictive diets to reduce
glutamate intake and the treatment of the GABA deficiency with GABA-agonists
such as Baclofen, Zolpidem, Progabide, Gaboxadol, and Gabapentin, amongst
others. There is a huge market for these drugs with annual sales over $2
billion. In addition, in what can only be considered as biochemical naivety, the
children are place on diets that supposedly are low in Glutamate, BUT, Glutamate
is a non-essential amino acid, so even in complete dietary insufficiency the
body can make glutamate, as it is not an essential amino acid. Treatment SHOULD
involve fixing the functional I/Se deficiency NOT treatment with a GABA agonist.
Potentially other conditions such as anxiety disorder, Tourette's syndrome,
schizophrenia, which are all treated with these also have the same deficiency,
and so would represent other mistreatments. Levels
of oxalates can be very high in conditions such as CFS and autism. These high
levels of oxalates can cause pain in the joints, and the break-down product
ethyl malonic acid has been associated with developmental delay (Di Mio etal,
2017). One of the common myths is that oxalates are derived from the consumption
of high oxalate foods, however, elevated oxalates in urine come from the
metabolism of glycine, glycolate and hydroxyproline. Normally the oxalate is
converted back to glycolic acid, but in functional B2 deficiency, this does not
happen.
Jiang etal, 2012
There is a popular theory put forwards by Dr Theoharides and others (Theoharides,
et al, 2016; 2013; Alam et al, 2017; Doeyas, 2018; Prata, et al, 2017; Al-Haddad
et al, 2019; Wong 2022) that autism is caused by brain inflammation. Examination of
publications by these authors does not reveal any convincing data to support the
theory, and suggests that this may theory may be wrong (Wong, 2022). Of note is that the elevated neurotransmitter metabolites, HVA, VMA, QA,
and KA that occur due to functional B12 deficiency, have often been cited as
inflammatory markers with little evidence to support that contention. These
metabolites are known to be over-produced in vitamin B12 deficiency (See
Russell-Jones,
2023) Magnetic E (for
Electroencephalogram/Electrocardiogram) Resonance Treatment,
a non-invasive, non-pharmaceutical
and personalized form of
ineffective
neuromodulation. It appears to be based on the principle that
autism is due to an inflammatory response in the brain that can be modulated by
changing magnetic fields. Another treatment that should have "Quack-watch" Buyer
beware. Unbelievably the treatment is covered by
the NDIS.
Following the concept that it is altered immune response in the brain that
causes autism, recently GcMAF therapy, which is designed to activate
macrophages, with the thought (or lack thereof) that this will overcome the
immune dysfunction in autism. The result appears to be similar to that seen in
Long COVID,
in which hyperferritinemia, typical of Macrophage Activation Syndrome (MAS)
(Rosario et al, 2013; Kernan and Carcillo, 2017), is observed and the
biochemical markers of vitamin B2 deficiency become elevated and markers of
functional iron deficiency such as lowered Haemoglobin, lower Haematocrit and
elevated citrate are observed. In addition functional B12 deficiency becomes
worse. This has resulted in the treated individuals actually getting worse,
which would also be expected considering, what happens in Long COVID, in which
there is extensive macrophage activation. This was not mentioned by the
company
There are many people who believe that autism is due to some genetic
predisposition. There is evidence that there are some mutations in those with
autism, however closer scrutiny reveals that the condition cannot be
predominantly of genetic origin. Hence the incidence of autism has increased
from around 1 in 1000, 25 year ago, the incidence has dramatically increased
over the past 25 years, and is now 1 to 30 (South Korea) 1 in 35 (in the US) and
around one in 40 in Australia (as of 2021). Clearly there is no genetic method
of increasing the incidence of a non-lethal mutation in the population by over
200-fold within one generation. Despite this obvious disconnect, many research
groups are still labouring to prove a genetic link for the condition. Despite
this, several groups are clinging to the concept that autism is due to mutations
in the MTHFR gene, and have even developed an
MTHFR gene mutation protocol. These protocols appear to be generated with
little knowledge of basic genetics by either those peddling the protocol or the
poor unsuspecting parent going through with the protocol. Hence, the incidence
of the common MTHFR gene mutation C665T by pure genetics should mean that the
population as a whole would be 25% "-/-", 50% "+/-", and 25% "-/-", however, due
to selection in low dietary folate and functional B2 deficiency, there is a
change of ratio in the normal population to 10% "-/-", 37% "+/-", and 40% "-/-".
This is almost identical to the observed frequency in the population with autism
8.5% "-/-", 43.6% "+/-", and 47.9% "-/-". Hence, the actual frequency of the
"+/+" allele is less in the population with autism, NOT, more.
There are many claims that a deficiency in stem cells in the brains of children
with autism is somehow responsible for poor behaviour, anxiety, lack of social
skills, ability to focus and poor development of speech. The problem with this
theory is that there is very little evidence that stem cell numbers are reduced
in the brains of children with autism. Rather the lack of differentiation of the
resident stem cells is due to lack of stimulation by functional vitamin D and
the functional B12 deficiency, which causes a deficiency of melatonin. Melatonin
and vitamin D work together to stimulate the differentiation of neuronal stem
cells into oligodendrocytes, that subsequently are involved in the myelination
of neuronal cells in the brain. Despite this, many parents have been cajoled
into stem cell therapy for their children. Side effects have been reported to be
fever, tumour growth, abnormal bone growth, seizures, infection, allergic
reaction and immune system rejection have been reported.. In addition there has
been no evidence of efficacy of this approach, nor should there be, as the
problem is lack of functional B12 and vitamin D.
Several studies have been conducted into the link between autism
and epilepsy and have found that the presence
of intellectual disability (ID) contributes
to the risk factor for children with autism to develop epilepsy. Some of the
treatments include the use of GABA agonists or similar to inhibit the behaviour.
Unfortunately, the researchers fail to recognize that GABA insufficiency can be
expected in Iodine/Selenium deficiency due to the reduced production of FMN and
then the reduced activation of vitamin B6, with resultant reduction in
production of GABA. Some of the drugs used are highly addictive with strong side
effects. Drugs such as Carbamazine have strong side-effects such as balance
disorder, dizziness, drowsiness, nausea, vomiting, blurred vision, constipation
and dry mouth.
Many doctors misdiagnose elevated histamine in
the children as being due to Mast Cell Activation syndrome. The children are
then put on mast cell inhibitors such as Cromoglycate. This seems to come from a
misunderstanding of the poor maturation of the gut, due to the lack of
production of melatonin (see
melatoninlink).. This then means that the level of DAO, the enzyme that
normally inactivates histamine is reduced. Children that appear to be histamine
intolerant are then put on highly restrictive diets, which often produce even
more deficiencies in the children.
Gluten-intolerance in the community is relatively rare with an
incidence of 0.1 to 1.0%. This intolerance is a feature of those with Coeliac
Disease, a condition that rapidly resolves upon removal of gluten. Patients with
Coeliac disease can present with gastrointestinal symptoms such as diarrhoea,
malabsorption and weight loss. The condition does not cause developmental delay.
The incidence of the disease has not changed appreciably over the
past 20 years, yet the incidence of ASD has increased from one in 1000 (less
than the rate of Celiac disease) to now one in 35 in the US. Confirmation of
Coeliac disease is performed by measuring anti-gliadin antibodies. Despite the
low incidence of Coeliac Disease the number of people who are now on Gluten-free
diets has increased to up to 25% in countries such as the UK, USA and Australia.
Many adults claim to "feel" better on a GF diet, and it appears to be the first
dietary change that physicians use on children with ASD. This has many
disadvantages, firstly, there is no need to avoid gluten-products if you do not
have Coeliac disease, but secondly, most commercial breads are now fortified
with folate, vitamin B1, and Iodine. This then means that a child who is placed
on a gluten-free diet can often suffer these deficiencies as can be seen in OAT
analysis and HMTA. Further, since one of the major sources of Gluten-free flour
is rice, the children can take in huge quantities of arsenic and lead, which
would be "Contra" in a person who is already having developmental issues that
would be further affected by lead and arsenic poisoning. Potentially, one of the
reasons that persons react to commercial breads, is not actually due to the
gluten, but rather to the sulphite used as a preservative in many foods.
Sulphite is normally converted to Sulphate in the body by a Molybdenum-dependent
enzyme, Sulphite Oxidase, and in Molybdenum deficiency persons get an
intolerance to sulphite, which then may lead to diarrhea, gut issues and
malabsorption. In house studies have shown that Molybdenum deficiency is very
common in children with ASD, with over 45 % of children with ASD having
Molybdenum deficiency via HMTA. Molybdenum deficiency is now so common in the
community that the range for Molybdenum in HMTA performed by Doctors Data has
shifted from 0.05-0.13 ppm in the 1990s, to now being out of range low 0.02-0.05
ppm in 2020, with over 70% of ASD individuals having Mo below 0.07 ppm.
Interestingly, although Coeliac disease does not cause developmental delay,
several studies have shown that sulphite is neurotoxic and in severe cases can
cause neonatal seizures, developmental delay, feeding difficulties,
microcephaly, brain atrophy and spasticity (Ergene etal, 2021; Grings etal,
2016; Veldman etal, 2010;
Jakubiczka-Smorag,etal 2016) and neuronal loss in the
hippocampus (Kocamaz
etal, 2012).
Accumulation of arsenic in the hair of an 18 month child (top) exclusively fed on
breast-milk from a gluten-free mother ((bottom).
Essential minerals of arsenic in the hair of an 18 month child exclusively fed
on breast-milk from a gluten-free mother (top), Mother (bottom).
Note the
Selenium and Molybdenum deficiencies of both mother (bottom) and child (top).
Arsenic accumulation is common in rice, the main food used in the production of
gluten-free flour (Abedin etal, 2002). It also bioaccumulates in milk in areas
of high local arsenic contamination (Freire
et al, 2022;
Salcedo et al, 2022; Bassil et al, 2017).
Elevated arsenic levels are a well-known complication/association of gluten-free
diets (Punshen and Jacksen, 2018; Carey et al, 2018;
Raehsler et al, 2018;
Munera-Picazo, et al, 2014; Burlo etal, 2011}. Curiously, despite the known
association of arsenic with developmental delay and brain damage, the standard
food restriction for children with autism is a gluten-free diet.
Choline, a methylation product is an essential part of the
phospholipid, Phosphatidylcholine, an important lipid in the brain, it is also
part of the neurotransmitter acetyl-choline. Choline can also be broken down to
form betaine, a methyldonor for formation of 5MTHF. Supplementation studies with
choline, however have not been shown to be effective in the improving language
or cognition (Li et al, 2022; Lebel et al, 2016; Strain et al, 2013). Some
effect was seen when an Acetyl-Cholinesterase inhibitor, plus choline was given,
however a control with just the ACE-inhibitor was not used (Gabis etal, 2019);
In individuals with a lack of vitamin B12, there is a reduced
production of melatonin, due to the lack of SAM to convert serotonin, either
produced in the gut or the brain, to melatonin. Gastro-intestinal problems are
common in individuals with low vitamin B12, and it is thought that melatonin has
a role to play in the maturation of the gut wall. Furthermore, low vitamin B12
is also associated with lack of activity of the enzyme histamine-N-methyl
transferase, an enzyme secreted in the gut wall that inactivates histamine, and
allows nutritionally normal people to consume foods with large amounts of
histamine in them. Since the allergic response to food allergens is the same as
that of histamine intolerance it is easy to assume that symptoms such as
flushing, urticarial, Rhinoconjunctivitis and rhinorrhea, Headaches,
and Digestive
tract disturbances: abdominal pain, diarrhea, nausea, vomiting are similar to
those from histamine intolerance, many parents assume that these types of
symptoms are caused by food allergy, and as such go on highly restrictive diets,
such as the GFCF diet. Somewhat illogically they assume that the ASD child will
then be cured. Early onset dairy intolerance/cow’s milk allergy is relatively
infrequent and occurs in around 2-7% of children, however, the allergy generally
resolves within a few years (Turck 2013; Denis etal, 2012). The incidence of
cow’s milk allergy was significantly lower in exclusively breast fed children
(Chandra and Hamad 1991).There is as yet no evidence that ASD is caused by
allergy to cow’s milk or that the use of a diet free of cow’s milk is of benefit
in treatment of individuals with ASD (Turck, 2013). In addition, lower intake of
milk has been associated with lower adolescent bone mineral density (Blanco etal,
2017). There are also no studies comparing the incidence of cow’s milk allergy
in normally developing children and those with autism spectrum disorder. The
presence of IgE antibodies in serum of individuals does not necessarily
correlate with allergic status, nor skin prick testing, but rather oral
challenge is more predictive of allergic status (Chauveau etal, 2016). Usually
cow’s milk can be re-introduced after 6 months of exclusion (Denis etal, 2012).
There are considerable logical problems with the adoption of the
GFCF diet.
1.
The children are known to be
deficient in both vitamin B12 and vitamin B2, which arguably causes the
perceived symptomology.
2.
Placing the children on GFCF
diets increases the level of B2 deficiency, and in countries which supplement
iodine into cows to produce iodized milk, the children then become iodine
deficient. The combined B2/Iodine deficiency causes an even greater deficiency
in vitamin B12.
3.
Adopting the gluten free diet
adds further deficiencies to the mix as now the child becomes vitamin B1
deficient, and often selenium and molybdenum deficient.
4.
Removing dairy from the diet
then causes calcium deficiency and extremely elevated levels of phosphoric acid
are present in the urine, reflecting stripping of the soluble calcium-phosphate
pool from the bone, and thereby reducing the bone density of the children.
5.
It doesn’t cure autism, but it
can take a child who should have been treated with vitamin B2 and vitamin B12,
and makes them more B2 and B12 deficient and in addition makes them potentially
vitamin B1 deficient, Iodine, Selenium and molybdenum deficient and also calcium
deficient. The insult is further exacerbated if the child is also taken off
eggs, as this generally will make them biotin deficient.
6.
Given that each of the
deficiencies can by themselves lead to demyelination of nerves, and given that
these deficiencies have also been associated with the development of dementia,
it seems almost inconceivable that such treatment is given to the children, yet
it is extremely common.
Applied Behavioural Analysis Therapy, is the practice of applying
psychological principles of learning theory in a systematic way to modify
behaviour. Similar practice is carried out in dementia. Speech and Language
Therapy (SLT) is a similar practise. The people who practice
it, firstly charge a lot of money, but secondly, they have the belief (both in ASD and Dementia) that somehow you can over-come the metabolic deficiencies that
the people have by psychological principles. Given that it is the biochemical
deficits, particularly in the altered neuronal signalling, that causes the
behavioural and learning problems in ASD, it is not logical to assume that you
could "talk, or reason" the condition away. It would be about as effective as
talking to a raging bush-fire in order to get it to put itself out!!
Another "theory" of autism is that the children have Pediatric
autoimmune neuropthychiatric disorders, asssociated with streptoccal infections
(PANDAS). The theory is supposed to apply to a subset of children with OCD or
TIC disorders. Specifically the theory applies to Group A streptococci, an
extremely common pathogen in children, particularly those who repeatedly have
sore throats. The theory seems to piggy-back on conditions such as Post
Streptococcal nephritis and Post Streptococcal theumatic heart disease and Post
Streptococcal glomerulophritis. Of the many problems with the theory is that all
children with autism are biochemically the same. They all have functional B2
deficiency and functional B12 deficiency, which alone explains the condition.
Biofeedback involves trying to retrain the brain of children to function more
effectively. The problem with the technique is that it is the biochemical
deficiencies in the brain that are the reason for the poor performance of the
brains of the children. Fix the Biochemistry and then the children will perform
much better. The cost is $50-500 per session, depending upon the insurance cover
(which one would question) with 30-50 sessions required. Hence the cost would be
$1500 to $25,000. Little wonder that they try to push the technique!! to
Bioresonance
Bioresonance is a classed as a Pseudoscience in which
Practitioners claim to be able to detect a variety of conditions, such as
autism, and treatment consists of treating autism without drugs by stimulating a
change of "bioresonance" in the body. Scientific evaluation has not shown any
advance over and above the placebo effect. Once again the issue in Autism is the
deficiencies in vitamin B2 and vitamin B12. Such deficiencies cannot be changed
by electrical impulses such as are used in Bioresonance
The majority of children who have recently been diagnosed with
ASD have elevated B12, and as such are not deemed to be vitamin B12 deficient.
Hence there is the myth that vitamin B12 deficiency is NOT the cause of ASD.
Metabolic analysis using urinary Organic Acids (OAT) reveals that the children
are actually very deficient in both Adenosyl and particularly Methyl B12, which
is contrary to the elevated serum B12, as such the children have "Paradoxical B12 deficiency".
"Paradoxical B12 deficiency" is particularly common in ASD, CFS, PD and AD. Examples can be seen at
https://b12oils.com/b12.htm
Ergene M, Yarar N, Öncel EP, Sezer T, Çavdarlı B, Ecevit İZ, Aydın Hİ. Severe
isolated sulfide oxidase deficiency with a novel mutation. Turk J Pediatr.
2021;63(4):716-720. doi: 10.24953/turkjped.2021.04.021. PMID: 34449156.
Grings M, Moura AP, Parmeggiani B, Motta MM, Boldrini RM, August PM, Matté C,
Wyse AT, Wajner M, Leipnitz G. Higher susceptibility of cerebral cortex and
striatum to sulfite neurotoxicity in sulfite oxidase-deficient rats. Biochim
Biophys Acta. 2016 Nov;1862(11):2063-2074. doi: 10.1016/j.bbadis.2016.08.007.
Epub 2016 Aug 12. PMID: 27523630.
Veldman A, Santamaria-Araujo JA, Sollazzo S, Pitt J, Gianello R, Yaplito-Lee J,
Wong F, Ramsden CA, Reiss J, Cook I, Fairweather J, Schwarz G. Successful
treatment of molybdenum cofactor deficiency type A with cPMP. Pediatrics. 2010
May;125(5):e1249-54. doi: 10.1542/peds.2009-2192. Epub 2010 Apr 12. PMID:
20385644.
Kocamaz E, Adiguzel E, Er B, Gundogdu G, Kucukatay V. Sulfite leads to neuron
loss in the hippocampus of both normal and SOX-deficient rats. Neurochem Int.
2012 Aug;61(3):341-6. doi: 10.1016/j.neuint.2012.06.010. Epub 2012 Jun 16. PMID:
22709673.
Jakubiczka-Smorag J, Santamaria-Araujo JA, Metz I, Kumar A, Hakroush S, Brueck
W, Schwarz G, Burfeind P, Reiss J, Smorag L. Mouse model for molybdenum cofactor
deficiency type B recapitulates the phenotype observed in molybdenum cofactor
deficient patients. Hum Genet. 2016 Jul;135(7):813-26. doi:
10.1007/s00439-016-1676-4. Epub 2016 May 2. PMID: 27138983.
Theoharides TC, Stewart JM, Panagiotidou S, Melamed I.
Mast cells, brain inflammation and autism. Eur J Pharmacol. 2016 May
5;778:96-102. doi: 10.1016/j.ejphar.2015.03.086. Epub 2015 May 1. PMID:
25941080.
Alam R, Abdolmaleky HM, Zhou JR. Microbiome, inflammation,
epigenetic alterations, and mental diseases. Am J Med Genet B Neuropsychiatr
Genet. 2017 Sep;174(6):651-660. doi: 10.1002/ajmg.b.32567. Epub 2017 Jul 10.
PMID: 28691768.
Doenyas C. Gut Microbiota, Inflammation, and Probiotics on
Neural Development in Autism Spectrum Disorder. Neuroscience. 2018 Mar
15;374:271-286. doi: 10.1016/j.neuroscience.2018.01.060. Epub 2018 Feb 8. PMID:
29427656.
Theoharides TC, Asadi S, Patel AB. Focal brain
inflammation and autism. J Neuroinflammation. 2013 Apr 9;10:46. doi:
10.1186/1742-2094-10-46. PMID: 23570274; PMCID: PMC3626551.
Prata J, Santos SG, Almeida MI, Coelho R, Barbosa MA.
Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and
biomarkers - pre-clinical and clinical investigations. J Neuroinflammation. 2017
Sep 4;14(1):179. doi: 10.1186/s12974-017-0938-y. PMID: 28870209; PMCID:
PMC5584030.
Al-Haddad BJS, Oler E, Armistead B, Elsayed NA, Weinberger
DR, Bernier R, Burd I, Kapur R, Jacobsson B, Wang C, Mysorekar I, Rajagopal L,
Adams Waldorf KM. The fetal origins of mental illness. Am J Obstet Gynecol. 2019
Dec;221(6):549-562. doi: 10.1016/j.ajog.2019.06.013. Epub 2019 Jun 15. PMID:
31207234; PMCID: PMC6889013.
Wong, RSY, 2022. Neuroinflammation in autism spectrum
disorders; potential target for mesenchymal stem cell-based therapy. EJNP, 58-91
Abedin, M. J., Cresser, M. S., Meharg, A. A., Feldmann, J., & Cotter-Howells, J.
(2002). Arsenic accumulation and metabolism in rice (Oryza sativa L.). Environmental
Science & Technology, 36(5),
962–968. https://doi.org/10.1021/es0101678.
Freire C, Iribarne-Durán LM, Gil F, Olmedo P, Serrano-Lopez L, Peña-Caballero M,
Hurtado JA, Alvarado-González NE, Fernández MF, Peinado FM, Artacho-Cordón F,
Olea N. Concentrations and determinants of lead, mercury, cadmium, and arsenic
in pooled donor breast milk in Spain. Int J Hyg Environ Health. 2022
Mar;240:113914. doi: 10.1016/j.ijheh.2021.113914. Epub 2021 Dec 31. PMID:
34974272.
García Salcedo JJ, Roh T, Nava Rivera LE, Betancourt Martínez ND, Carranza
Rosales P, San Miguel Salazar MF, Rivera Guillén MA, Serrano Gallardo LB, Niño
Castañeda MS, Guzmán Delgado NE, Millán Orozco J, Ortega Morales N, Morán
Martínez J. Comparative Biomonitoring of Arsenic Exposure in Mothers and Their
Neonates in Comarca Lagunera, Mexico. Int J Environ Res Public Health. 2022 Dec
4;19(23):16232. doi: 10.3390/ijerph192316232. PMID: 36498305; PMCID: PMC9739351.
Jiang, J, Johnson, LC, Knight J, et al, 2012. Metabolism of
[13C5]hydroxyproline
in vitro and in vivo: implications for primary hyperoxaluria
American Journal of Physiology-Gastrointestinal and Liver Physiology 2012 302:6, G637-G643
Bassil M, Daou F, Hassan H, Yamani O, Kharma JA, Attieh Z, Elaridi J. Lead,
cadmium and arsenic in human milk and their socio-demographic and lifestyle
determinants in Lebanon. Chemosphere. 2018 Jan;191:911-921. doi:
10.1016/j.chemosphere.2017.10.111. Epub 2017 Oct 27. PMID: 29145136.
Punshon T, Jackson BP. Essential micronutrient and toxic trace element
concentrations in gluten containing and gluten-free foods. Food Chem. 2018 Jun
30;252:258-264. doi: 10.1016/j.foodchem.2018.01.120. PMID: 29478539; PMCID:
PMC5830128.
Carey M, Donaldson E, Signes-Pastor AJ, Meharg AA. Dilution of rice with other
gluten free grains to lower inorganic arsenic in foods for young children in
response to European Union regulations provides impetus to setting stricter
standards. PLoS One. 2018 Mar 16;13(3):e0194700. doi:
10.1371/journal.pone.0194700. PMID: 29547635; PMCID: PMC5856424.
Raehsler SL, Choung RS, Marietta EV, Murray JA. Accumulation of Heavy Metals in
People on a Gluten-Free Diet. Clin Gastroenterol Hepatol. 2018
Feb;16(2):244-251. doi: 10.1016/j.cgh.2017.01.034. Epub 2017 Feb 20. PMID:
28223206.
Munera-Picazo S, Ramírez-Gandolfo A, Burló F, Carbonell-Barrachina AA. Inorganic
and total arsenic contents in rice-based foods for children with celiac disease.
J Food Sci. 2014 Jan;79(1):T122-8. doi: 10.1111/1750-3841.12310. Epub 2013 Dec
6. PMID: 24313911.
Di Meo I, Lamperti C, Tiranti V. Ethylmalonic Encephalopathy. 2017 Sep 21. In:
Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle
(WA): University of Washington, Seattle; 1993-2024. Available
from: https://www.ncbi.nlm.nih.gov/sites/books/NBK453432/
Li T, Samuel TM, Zhu Z, Howell B, Cho S, Baluyot K, Hazlett H, Elison JT, Wu D,
Hauser J, Sprenger N, Zhu H, Lin W. Joint analyses of human milk fatty acids,
phospholipids, and choline in association with cognition and temperament traits
during the first 6 months of life. Front Nutr. 2022 Aug 24;9:919769. doi:
10.3389/fnut.2022.919769. PMID: 36091236; PMCID: PMC9449418.
Lebel C, MacMaster FP, Dewey D. Brain metabolite levels and language abilities
in preschool children. Brain Behav. 2016 Aug 11;6(10):e00547. doi:
10.1002/brb3.547. Erratum in: Brain Behav. 2016 Dec 19;6(12 ):e00623. PMID:
27781150; PMCID: PMC5064348.
Strain JJ, McSorley EM, van Wijngaarden E, Kobrosly RW, Bonham MP, Mulhern MS,
McAfee AJ, Davidson PW, Shamlaye CF, Henderson J, Watson GE, Thurston SW,
Wallace JM, Ueland PM, Myers GJ. Choline status and neurodevelopmental outcomes
at 5 years of age in the Seychelles Child Development Nutrition Study. Br J Nutr.
2013 Jul 28;110(2):330-6. doi: 10.1017/S0007114512005077. Epub 2013 Jan 9. PMID:
23298754; PMCID: PMC3723412.
Gabis LV, Ben-Hur R, Shefer S, Jokel A, Shalom DB. Improvement of Language in
Children with Autism with Combined Donepezil and Choline Treatment. J Mol
Neurosci. 2019 Oct;69(2):224-234. doi: 10.1007/s12031-019-01351-7. Epub 2019 Jun
22. PMID: 31230222.
Burló F, Ramírez-Gandolfo A, Signes-Pastor AJ, Haris PI, Carbonell-Barrachina
AA. Arsenic contents in Spanish infant rice, pureed infant foods, and rice. J
Food Sci. 2012 Jan;77(1):T15-9. doi: 10.1111/j.1750-3841.2011.02502.x. Epub 2011
Dec 19. PMID: 22181972.
GcMAF
Therapy for Autism | Saisei Immunotherapy Clinics (saisei-mirai.or.jp)
Copyright © 2018 B12 Oils. All Rights Reserved.
MYTHS AND MISTREATMENTS
Autism
Paradigm
Nemechek
Protocol
Cutler
Chelation Therapy

Toxin
Removal
Vaccine Injured
Elevated Propionic Acid
Cerebral Folate Deficiency
Elevated Glutamate
Elevated Oxalates

Inflammation in the Brain in Autism
MeRT
GcMAF therapy and Autism
Autism is due to Genetics
Autism and Stem Cell Therapy
Treatment of Epilepsy
Treatment of Elevated Histamine
Gluten Free Diets




Choline Supplementation
Lactose Intolerance, and Dairy Free Diets
ABA Therapy and SLT
PANS/PANDAS
and Homeopathy
Biofeedback
Paradoxical vitamin B12 deficiency
References
Reproduction in whole or in part in any form or medium without express written
permission is prohibited